Untreated CD30-Positive Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Untreated CD30-Positive Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma" (NCT03729609) | Takeda | 2018-11-01 |
Track Untreated CD30-Positive Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.